<DOC>
	<DOCNO>NCT01305655</DOCNO>
	<brief_summary>Early intervention child adolescent experience delay MTX-clearance renal dysfunction ALL treatment enzyme Glucarpidase rapidly hydrolyse MTX non-toxic metabolite avoid life threatening complication .</brief_summary>
	<brief_title>Glucarpidase Effect Severe Delayed HDM-clearance Children Treated With High-dose Mtx ALL</brief_title>
	<detailed_description>The NOPHO ALL-2008 protocol treatment research protocol aim improve overall outcome Nordic child adolescents ALL comparison ALL-2000 protocol aim reduce prevent toxic treatment complication high-dose methotrexate ( HD-MTX ) . The specific primary objective randomize study : 1 . Early intervention child adolescent experience delay MTX-clearance renal dysfunction enzyme Glucarpidase rapidly hydrolyse MTX non-toxic metabolite lower serum concentration avoid life threaten complication . Glucarpidase give 24 hour level MTX &gt; 250 µM , 36 hour level &gt; 30 µM 42 hour level &gt; 10 µM together reduce kidney function . Glucarpidase treatment take place within 48 hour start HD-MTX treatment . 2 . To evaluate early intervention Glucarpidase reduce number day patient stay hospital . 3 . Evaluate reduction health cost early intervention patient delay MTX-clearance renal dysfunction .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Children adolescent experience delay MTXclearance renal dysfunction highdose methotrexate treatment NOPHO ALL2008 . Children adolescents earlier anaphylactic reaction Glucarpidase . Pregnant patient .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Drug : Glucarpidase</keyword>
</DOC>